BIO - Bio-Rad Laboratories Inc
This page shows which of the focused investors we track hold BIO and how their positions changed, so you can see how much conviction the group has in the stock.
In Q2 2023 it was held by 3 managers with an aggregate reported value of $125.15M, which is 0.01% of the combined portfolio.
As of Q2 2023, 3 tracked institutional managers held BIO (Bio-Rad Laboratories Inc) with an aggregate reported value of $125.15M — 0.01% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades BIO — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q2 2023
- Ticker
- BIO
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Mason Hawkins - Southeastern Asset Management | 4.35% | New | 325,519 | $123.41M |
| 2 | Ariel Investments - Ariel Investments | 0.02% | Reduce -86.2% | 4,393 | $1.67M |
| 3 | First Eagle - First Eagle Investment Management | 0.00% | New | 191 | $72.41K |
Loading holder history for BIO…